Vitamin K1 Related Published Studies
Well-designed clinical trials related to Vitamin K1 (Phytonadione)
Vitamin K supplementation and progression of coronary artery calcium in older men and women. [2009.06]
Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status. [2009.04]
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. [2009.03.03]
Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. [2009.02]
Vitamin K in hand osteoarthritis: results from a randomised clinical trial. [2008.11]
Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. [2008.10.14]
Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women. [2008.09]
Vitamin K, circulating cytokines, and bone mineral density in older men and women. [2008.08]
Effect of vitamin K supplementation on bone loss in elderly men and women. [2008.04]
Vitamin K1 versus Vitamin K3 for Prevention of Subclinical Vitamin Deficiency: A Randomized Controlled Trial. [2007.11.07]
Effect of Consumption of Micronutrient Fortified Candies on the Iron and Vitamin A Status of Children Aged 3-6 years in Rural Haryana. [2007.11.07]
Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial. [2007.11]
Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. [2007.10]
Daily vitamin K supplementation improves anticoagulant stability. [2007.10]
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. [2007.09.25]
Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. [2007.07]
Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K. [2007.07]
Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. [2007.04]
Vitamin K prophylaxis for preterm infants: a randomized, controlled trial of 3 regimens. [2006.12]
Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women. [2006.11]
Effect of calcium, vitamins K(1) and D(3) on bone in galactosemia. [2006.11]
The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation. [2006.10]
Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage: is it effective? [2006.06]
Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants. [2006]
Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. [2005.03]
Well-designed clinical trials possibly related to Vitamin K1 (Phytonadione)
Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women. [2008.10]
Topical amethocaine gel 4% for intramuscular injection in term neonates: A double-blind, placebo-controlled, randomized trial. [2008.01]
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. [2008.01]
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. [2007.11.27]
Idraparinux versus standard therapy for venous thromboembolic disease. [2007.09.13]
Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients. [2007.09]
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. [2007.07.10]
low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP). [2007.07]
Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South african children: a randomized controlled trial. [2007.06.27]
Diuretic, hypotensive, and hypocholesterolemic effects of Eclipta alba in mild hypertensive subjects: a pilot study. [2007.03]
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms. [2007.01]
Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture. [2007]
Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism. [2006]
Other research related to Vitamin K1 (Phytonadione)
Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? [2009.10]
Vitamin K to prevent fractures in older women: systematic review and economic evaluation. [2009.09]
Purification, characterization, and directed evolution study of a vitamin D3 hydroxylase from Pseudonocardia autotrophica. [2009.07.24]
Effects of vitamin K1 on fluoride-induced bone changes in growing rats: a histomorphometric and radiodensitometric study. [2009.06]
CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant. [2009.06]
Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. [2009.06]
The association between dietary vitamin K intake and serum undercarboxylated osteocalcin is modulated by vitamin K epoxide reductase genotype. [2009.06]
High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. [2009.04]
Late vitamin K deficiency bleeding after intramuscular prophylaxis at birth: a case report. [2009.02]
Vitamin K, an update for the paediatrician. [2009.02]
Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. [2009.01]
HPLC-APCI-MS for the determination of vitamin K(1) in human plasma: method and clinical application. [2008.11.15]
A stable isotope method for the simultaneous measurement of vitamin K1 (phylloquinone) kinetics and absorption. [2008.11]
[Vitamin K2] [2008.10]
Update on the role of vitamin K in skeletal health. [2008.10]
Vitamin K supplementation to decrease variability of International Normalized Ratio in patients on vitamin K antagonists: a literature review. [2008.09]
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. [2008.09]
Does high vitamin K1 intake protect against bone loss in later life? [2008.09]
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. [2008.05.27]
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. [2008.05]
A practice survey of shoulder glucocorticoid injections in patients on antiplatelet drugs or vitamin K antagonists. [2008.05]
The relationship between maintenance dosages of three vitamin K antagonists: Acenocoumarol, warfarin and phenprocoumon. [2008.04.11]
Low vitamin D status adversely affects bone health parameters in adolescents. [2008.04]
Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). [2008.04]
Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. [2008.04]
Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline. [2008.02]
Vitamin K and D association stimulates in vitro osteoblast differentiation of fracture site derived human mesenchymal stem cells. [2008.01]
Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K(2) in postmenopausal women. [2008]
Hepatocellular carcinoma and vitamin K. [2008]
Vitamin K and bone health in adult humans. [2008]
Vitamin K and thrombosis. [2008]
The vitamin K cycle. [2008]
Vitamin K content of foods and dietary vitamin K intake in Japanese young women. [2007.12]
Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. [2007.10]
Vitamin K deficiency of germfree mice caused by feeding standard purified diet sterilized by gamma-irradiation. [2007.07]
[Vitamin K epoxide reductase complex 1 gene polymorphism and warfarin dose requirement in Chinese patients] [2007.07]
Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. [2007.04.15]
Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. [2007.04.01]
Subclinical vitamin K deficiency in hemodialysis patients. [2007.03]
Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women. [2007.02]
Dietary vitamin K intake and anticoagulation in elderly patients. [2007.01]
Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-7 and 2000-1. [2006.12]
A preliminary assessment of vitamin K1 intakes and serum undercarboxylated osteocalcin levels in 11-13 year old Irish girls. [2006.11]
[Protective effects of vitamin K against osteoporosis and its pleiotropic actions] [2006.09]
Pleiotropic actions of vitamin K: protector of bone health and beyond? [2006.07]
Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. [2006.06.26]
Fat-soluble vitamins in breast-fed preterm and term infants. [2006.06]
Reversal of asymptomatic over-anticoagulation by orally administered vitamin K. [2006.05]
Phylloquinone (vitamin K1) intakes and serum undercarboxylated osteocalcin levels in Irish postmenopausal women. [2006.05]
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. [2006.02.27]
Menadione is a metabolite of oral vitamin K. [2006.02]
Subclinical hypervitaminosis A in rat: measurements of bone mineral density (BMD) do not reveal adverse skeletal changes. [2006.01.05]
No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. [2006]
Association of dietary and biochemical measures of vitamin K with quantitative ultrasound of the heel in men and women. [2006]
Vitamin K status of preterm infants with a prolonged prothrombin time. [2005.12]
[Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K(1) on their activity.] [2005.12]
Effect of apolipoprotein E genotype on vitamin K status in healthy older adults from China and the UK. [2005.12]
Effects of vitamin K(1) on fluoride-induced bone changes in growing rats: a histomorphometric and radiodensitometric study. [2005.10]
Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. [2005.08.01]
Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. [2005.05]
Vitamin K1 intake and coronary calcification. [2005.05]
Viability and plasma vitamin K levels in the common bile duct-ligated rats. [2005.04]
Intake and sources of phylloquinone (vitamin K(1)) in 4-year-old British children: comparison between 1950 and the 1990s. [2005.04]
|
